{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:32:09Z","timestamp":1757611929510,"version":"3.44.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,3]]},"DOI":"10.7759\/cureus.91568","type":"journal-article","created":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T04:53:18Z","timestamp":1756961598000},"source":"Crossref","is-referenced-by-count":0,"title":["Indian Interventional Cardiologists\u2019 Perspectives on De-escalating Dual to Single Antiplatelet Therapy in High Bleeding Risk (HBR) Patients"],"prefix":"10.7759","author":[{"given":"Jagdish Chander","family":"Mohan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saumitra","family":"Ray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abraham","family":"Oomman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shah","family":"VT","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baishali","family":"Nath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anand","family":"Chitre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study","volume":"76","author":"Roth GA","year":"2020","unstructured":"Roth GA, Mensah GA, Johnson CO, et al.. Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study. J Am Coll Cardiol. 2020, 76:2982-3021. 10.1016\/j.jacc.2020.11.010","journal-title":"J Am Coll Cardiol"},{"key":"ref2","article-title":"Epidemiology of acute coronary syndromes in India","author":"Gupta R","year":"2020","unstructured":"Gupta R, Gaur K. Epidemiology of acute coronary syndromes in India. Acute Coronary Syndromes. CRC Press, Florida, USA; 2020. 1:11."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.21037\/atm.2016.06.33","article-title":"Epidemiology of coronary heart disease and acute coronary syndrome","volume":"4","author":"Sanchis-Gomar F","year":"2016","unstructured":"Sanchis-Gomar F, Perez-Quilis C, Leischik R, Lucia A. Epidemiology of coronary heart disease and acute coronary syndrome. Ann Transl Med. 2016, 4:256. 10.21037\/atm.2016.06.33","journal-title":"Ann Transl Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jscai.2023.100930","article-title":"E-20| appropriateness of percutaneous coronary intervention under Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB-PMJAY)","volume":"2","author":"Bhanu D","year":"2023","unstructured":"Bhanu D, Gupta I, Kumar U, Rayapati V, Saunik S, Gedam P. E-20| appropriateness of percutaneous coronary intervention under Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB-PMJAY). J Soc Cardiovasc Angiogr Interv. 2023, 2:100930. 10.1016\/j.jscai.2023.100930","journal-title":"J Soc Cardiovasc Angiogr Interv"},{"key":"ref5","article-title":"High-risk percutaneous coronary intervention: challenges and considerations","volume":"3","author":"Gogineni VS","year":"2024","unstructured":"Gogineni VS, Shah KB. High-risk percutaneous coronary intervention: challenges and considerations.  Cardiovasc Innov Appl. 2024, 3:949.","journal-title":"Cardiovasc Innov Appl"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-23-0750","article-title":"Potent P2y(12) inhibitor monotherapy for acute coronary syndrome","volume":"89","author":"Hong SJ","year":"2025","unstructured":"Hong SJ, Kim BK. Potent P2y(12) inhibitor monotherapy for acute coronary syndrome. Circ J. 2025, 89:272-80. 10.1253\/circj.CJ-23-0750","journal-title":"Circ J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC Guidelines for the management of acute coronary syndromes: developed by the task force on the management of acute coronary syndromes of the European Society of Cardiology (ESC)","volume":"44","author":"Byrne RA","year":"2023","unstructured":"Byrne RA, Rossello X, Coughlan JJ, et al.. 2023 ESC Guidelines for the management of acute coronary syndromes: developed by the task force on the management of acute coronary syndromes of the European Society of Cardiology (ESC). Eur Heart J. 2023, 44:3720-826. 10.1093\/eurheartj\/ehad191","journal-title":"Eur Heart J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2024.11.009","article-title":"2025 ACC\/AHA\/ACEP\/NAEMSP\/SCAI guideline for the management of patients with acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines","volume":"85","author":"Rao SV","year":"2025","unstructured":"Rao SV, O'Donoghue ML, Ruel M, et al.. 2025 ACC\/AHA\/ACEP\/NAEMSP\/SCAI guideline for the management of patients with acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines. J Am Coll Cardiol. 2025, 85:2135-237. 10.1016\/j.jacc.2024.11.009","journal-title":"J Am Coll Cardiol"},{"key":"ref9","doi-asserted-by":"crossref","DOI":"10.4244\/EIJ-D-21-00904","article-title":"Antiplatelet therapy after percutaneous coronary intervention","volume":"17","author":"Angiolillo DJ","year":"2022","unstructured":"Angiolillo DJ, Galli M, Collet JP, Kastrati A, O'Donoghue ML. Antiplatelet therapy after percutaneous coronary intervention. EuroIntervent. 2022, 17:e1371-96.","journal-title":"EuroIntervent"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-023337","article-title":"Incidence and prognostic impact of post discharge bleeding post acute coronary syndrome within an outpatient setting: a systematic review","volume":"9","author":"Ismail N","year":"2019","unstructured":"Ismail N, Jordan KP, Rao S, Kinnaird T, Potts J, Kadam UT, Mamas MA. Incidence and prognostic impact of post discharge bleeding post acute coronary syndrome within an outpatient setting: a systematic review. BMJ Open. 2019, 9:e023337. 10.1136\/bmjopen-2018-023337","journal-title":"BMJ Open"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.119.040167","article-title":"Defining high bleeding risk in patients undergoing percutaneous coronary intervention","volume":"140","author":"Urban P","year":"2019","unstructured":"Urban P, Mehran R, Colleran R, et al.. Defining high bleeding risk in patients undergoing percutaneous coronary intervention. Circ. 2019, 140:240-61. 10.1161\/CIRCULATIONAHA.119.040167","journal-title":"Circ"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehae462","article-title":"Long-term outcomes of high bleeding risk patients undergoing percutaneous coronary intervention: a Korean nationwide registry","volume":"45","author":"Kang J","year":"2024","unstructured":"Kang J, Yun J, Park KW, et al.. Long-term outcomes of high bleeding risk patients undergoing percutaneous coronary intervention: a Korean nationwide registry. Eur Heart J. 2024, 45:3721-31. 10.1093\/eurheartj\/ehae462","journal-title":"Eur Heart J"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.59556\/japi.72.0515","article-title":"Indian perspective on de-escalation from dual antiplatelet therapy to single antiplatelet therapy study: a knowledge, attitude, and practice study among Indian interventional cardiologists","volume":"72","author":"Mohan JC","year":"2024","unstructured":"Mohan JC, Singhal A, Oomman A, Ray S, Shah VT, Nath B, Bachani D. Indian perspective on de-escalation from dual antiplatelet therapy to single antiplatelet therapy study: a knowledge, attitude, and practice study among Indian interventional cardiologists. J Assoc Physicians India. 2024, 72:68-78. 10.59556\/japi.72.0515","journal-title":"J Assoc Physicians India"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.5334\/gh.1290","article-title":"Cardiovascular outcomes among patients with acute coronary syndromes and diabetes: results from ACS Quik trial in India","volume":"19","author":"Alfaddagh A","year":"2024","unstructured":"Alfaddagh A, Khraishah H, Romeo GR, et al.. Cardiovascular outcomes among patients with acute coronary syndromes and diabetes: results from ACS Quik trial in India. Glob Heart. 2024, 19:37. 10.5334\/gh.1290","journal-title":"Glob Heart"},{"key":"ref15","unstructured":"Cardiological Society of India, Guidelines. CCSI. Position statement on diagnosis and management of acute coronary syndrome in patients with chronic kidney disease. Accessed on 21st August. (2025). https:\/\/www.csi.org.in\/guidelines."},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2016\/19091.8106","article-title":"A prospective study on prevalence and causes of anaemia in patients with acute coronary syndrome","volume":"10","author":"Bhavanadhar P","year":"2016","unstructured":"Bhavanadhar P, Srinivasan VR, Oruganti SS, Adiraju KP. A prospective study on prevalence and causes of anaemia in patients with acute coronary syndrome. J Clin Diagn Res. 2016, 10:OC01-5. 10.7860\/JCDR\/2016\/19091.8106","journal-title":"J Clin Diagn Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0292723","article-title":"Burden of dengue, leishmaniasis and lymphatic filariasis in India and its states from 1990-2019: Analysis from the Global Burden of Disease study (GBD 2019)","volume":"18","author":"Dutta O","year":"2023","unstructured":"Dutta O, Prasanth A, Kumari A, Akanksha K, Deeba F, Salam N. Burden of dengue, leishmaniasis and lymphatic filariasis in India and its states from 1990-2019: Analysis from the Global Burden of Disease study (GBD 2019). PLoS One. 2023, 18:e0292723. 10.1371\/journal.pone.0292723","journal-title":"PLoS One"},{"key":"ref18","article-title":"Dengue fever, thrombocytopaenia and management issues in post-coronary stenting patients","author":"Bhatia V","year":"2017","unstructured":"Bhatia V. Dengue fever, thrombocytopaenia and management issues in post-coronary stenting patients. AsiaIntervention. 2017, 99.","journal-title":"AsiaIntervention"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.4103\/0971-5916.245303","article-title":"National ethical guidelines for biomedical & health research involving human participants, 2017: a commentary","volume":"148","author":"Mathur R","year":"2018","unstructured":"Mathur R, Swaminathan S. National ethical guidelines for biomedical & health research involving human participants, 2017: a commentary. Indian J Med Res. 2018, 148:279-83. 10.4103\/0971-5916.245303","journal-title":"Indian J Med Res"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ihj.2024.01.009","article-title":"The prevalence of bleeding after percutaneous coronary interventions: a systematic review and meta-analysis","volume":"76","author":"Heidary Moghadam R","year":"2024","unstructured":"Heidary Moghadam R, Mohammadi A, Salari N, Ahmed A, Shohaimi S, Mohammadi M. The prevalence of bleeding after percutaneous coronary interventions: a systematic review and meta-analysis. Indian Heart J. 2024, 76:16-21. 10.1016\/j.ihj.2024.01.009","journal-title":"Indian Heart J"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacasi.2025.05.017","article-title":"Decoding bleeding risks and survival in patients undergoing percutaneous coronary intervention on antiplatelet therapy","author":"Chang CC","year":"2025","unstructured":"Chang CC, Ng AK, Kogame N, Huang PH, Kim BK, van Geuns RM. Decoding bleeding risks and survival in patients undergoing percutaneous coronary intervention on antiplatelet therapy. JACC Asia. 2025, 10.1016\/j.jacasi.2025.05.017","journal-title":"JACC Asia"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-20-0395","article-title":"Prevalence of the Academic Research Consortium for high bleeding risk criteria and prognostic value of a simplified definition","volume":"84","author":"Miura K","year":"2020","unstructured":"Miura K, Shimada T, Ohya M, et al.. Prevalence of the Academic Research Consortium for high bleeding risk criteria and prognostic value of a simplified definition. Circ J. 2020, 84:1560-7. 10.1253\/circj.CJ-20-0395","journal-title":"Circ J"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.4244\/EIJ-E-23-00046","article-title":"De-escalation from potent P2Y12 inhibitors to clopidogrel: an alternative to short DAPT duration in HBR patients?","volume":"19","author":"Cayla G","year":"2023","unstructured":"Cayla G, Lattuca B. De-escalation from potent P2Y12 inhibitors to clopidogrel: an alternative to short DAPT duration in HBR patients?. EuroIntervention. 2023, 19:e789-91. 10.4244\/EIJ-E-23-00046","journal-title":"EuroIntervention"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehac829","article-title":"Dual antiplatelet therapy de-escalation in acute coronary syndrome: an individual patient meta-analysis","volume":"44","author":"Kang J","year":"2023","unstructured":"Kang J, Rizas KD, Park KW, et al.. Dual antiplatelet therapy de-escalation in acute coronary syndrome: an individual patient meta-analysis. Eur Heart J. 2023, 44:1360-70. 10.1093\/eurheartj\/ehac829","journal-title":"Eur Heart J"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.4244\/EIJ-D-23-00427","article-title":"De-escalation from ticagrelor to clopidogrel in patients with acute myocardial infarction: the TALOS-AMI HBR substudy","volume":"19","author":"Kim MC","year":"2023","unstructured":"Kim MC, Ahn SG, Cho KH, et al.. De-escalation from ticagrelor to clopidogrel in patients with acute myocardial infarction: the TALOS-AMI HBR substudy. EuroIntervention. 2023, 19:e832-43. 10.4244\/EIJ-D-23-00427","journal-title":"EuroIntervention"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.03.070","article-title":"Validation of the academic research consortium high bleeding risk definition in contemporary PCI patients","volume":"75","author":"Cao D","year":"2020","unstructured":"Cao D, Mehran R, Dangas G, et al.. Validation of the academic research consortium high bleeding risk definition in contemporary PCI patients. J Am Coll Cardiol. 2020, 75:2711-22. 10.1016\/j.jacc.2020.03.070","journal-title":"J Am Coll Cardiol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2108749","article-title":"Dual antiplatelet therapy after PCI in patients at high bleeding risk","volume":"385","author":"Valgimigli M","year":"2021","unstructured":"Valgimigli M, Frigoli E, Heg D, et al.. Dual antiplatelet therapy after PCI in patients at high bleeding risk. N Engl J Med. 2021, 385:1643-55. 10.1056\/NEJMoa2108749","journal-title":"N Engl J Med"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare9020148","article-title":"A systematic review on bleeding risk scores\u2019 accuracy after percutaneous coronary interventions in acute and elective settings","volume":"9","author":"Brinza C","year":"2021","unstructured":"Brinza C, Burlacu A, Tinica G, Covic A, Macovei L. A systematic review on bleeding risk scores\u2019 accuracy after percutaneous coronary interventions in acute and elective settings. Healthcare (Basel). 2021, 9:148. 10.3390\/healthcare9020148","journal-title":"Healthcare (Basel)"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-023-02857-z","article-title":"Usefulness of the PRECISE-DAPT score at differentiating between ticagrelor and prasugrel for dual antiplatelet therapy initiation","volume":"56","author":"Ray A","year":"2023","unstructured":"Ray A, Najmi A, Khandelwal G, Jhaj R, Sadasivam B. Usefulness of the PRECISE-DAPT score at differentiating between ticagrelor and prasugrel for dual antiplatelet therapy initiation. J Thromb Thrombolysis. 2023, 56:411-3. 10.1007\/s11239-023-02857-z","journal-title":"J Thromb Thrombolysis"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.19-0512","article-title":"Continuation of dual antiplatelet therapy in a patient with a coronary artery stent with dengue hemorrhagic fever: a clinical conundrum","volume":"102","author":"Ehelepola ND","year":"2020","unstructured":"Ehelepola ND, Athurupana AA, Bowatte PG, Dissanayake WP. Continuation of dual antiplatelet therapy in a patient with a coronary artery stent with dengue hemorrhagic fever: a clinical conundrum. Am J Trop Med Hyg. 2020, 102:17-9. 10.4269\/ajtmh.19-0512","journal-title":"Am J Trop Med Hyg"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/387230-indian-interventional-cardiologists-perspectives-on-de-escalating-dual-to-single-antiplatelet-therapy-in-high-bleeding-risk-hbr-patients","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T04:53:22Z","timestamp":1756961602000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/387230-indian-interventional-cardiologists-perspectives-on-de-escalating-dual-to-single-antiplatelet-therapy-in-high-bleeding-risk-hbr-patients"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,3]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.91568","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,9,3]]}}}